JP2023549476A5 - - Google Patents
Info
- Publication number
- JP2023549476A5 JP2023549476A5 JP2023524474A JP2023524474A JP2023549476A5 JP 2023549476 A5 JP2023549476 A5 JP 2023549476A5 JP 2023524474 A JP2023524474 A JP 2023524474A JP 2023524474 A JP2023524474 A JP 2023524474A JP 2023549476 A5 JP2023549476 A5 JP 2023549476A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- polypeptide according
- seq
- polypeptide
- myc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063094766P | 2020-10-21 | 2020-10-21 | |
| US63/094,766 | 2020-10-21 | ||
| US202163152959P | 2021-02-24 | 2021-02-24 | |
| US63/152,959 | 2021-02-24 | ||
| US202163222697P | 2021-07-16 | 2021-07-16 | |
| US63/222,697 | 2021-07-16 | ||
| PCT/US2021/055979 WO2022087221A1 (en) | 2020-10-21 | 2021-10-21 | Transcription active complex targeting cancer drug from viral protein sequence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549476A JP2023549476A (ja) | 2023-11-27 |
| JP2023549476A5 true JP2023549476A5 (https=) | 2024-10-17 |
Family
ID=81290054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524474A Pending JP2023549476A (ja) | 2020-10-21 | 2021-10-21 | ウイルスタンパク質配列由来のがん薬物を標的とする転写活性複合体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12528840B2 (https=) |
| EP (1) | EP4232061A4 (https=) |
| JP (1) | JP2023549476A (https=) |
| KR (1) | KR20230092938A (https=) |
| AU (1) | AU2021365153A1 (https=) |
| CA (1) | CA3195795A1 (https=) |
| WO (1) | WO2022087221A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4616864A1 (en) * | 2024-03-11 | 2025-09-17 | Peptomyc, S.L. | Compound for the treatment of autoimmune diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060263382A1 (en) * | 1998-06-20 | 2006-11-23 | Richard Hotchkiss | Membrane-permeant peptide complexes for treatment of sepsis |
| WO2014127148A1 (en) | 2013-02-14 | 2014-08-21 | The J. David Gladstone Institutes | Compositions and methods of use thereof for identifying anti-viral agents |
| WO2019108134A1 (en) | 2017-11-29 | 2019-06-06 | Agency For Science, Technology And Research | Chimeric molecule for targeting c-myc in cells |
-
2021
- 2021-10-21 KR KR1020237015229A patent/KR20230092938A/ko active Pending
- 2021-10-21 JP JP2023524474A patent/JP2023549476A/ja active Pending
- 2021-10-21 CA CA3195795A patent/CA3195795A1/en active Pending
- 2021-10-21 AU AU2021365153A patent/AU2021365153A1/en active Pending
- 2021-10-21 EP EP21883870.4A patent/EP4232061A4/en active Pending
- 2021-10-21 WO PCT/US2021/055979 patent/WO2022087221A1/en not_active Ceased
- 2021-10-21 US US18/248,291 patent/US12528840B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Uppalapati et al. | A potent D-protein antagonist of VEGF-A is nonimmunogenic, metabolically stable, and longer-circulating in vivo | |
| EP2608809A2 (en) | Antibodies to matrix metalloproteinase 9 | |
| JP2002514053A (ja) | 核局在化配列を持つ、核タンパク輸送のペプチド阻害物質およびその使用方法 | |
| JP2019510739A (ja) | Ｇｆｒａｌ受容体療法 | |
| WO2013130078A1 (en) | Antibodies to matrix metalloproteinase 9 | |
| HUE025378T2 (hu) | Keresztreagáló Staphylococcus aureus ellenanyag | |
| JP6087289B2 (ja) | Ｎａｐｉ２ｂ輸送体に対するヒト化モノクローナル抗体の相補性決定領域に由来する抗腫瘍ペプチド | |
| JP2023549476A5 (https=) | ||
| CA2758449C (en) | Treatment of inflammatory diseases by inhibiting cold-inducible rna-binding protein (cirp) | |
| US6960566B1 (en) | Compositions and methods for treatment of cancer | |
| CN111601815A (zh) | 靶向细胞中c-Myc的嵌合分子 | |
| ES2836684T3 (es) | Proteína 2 que contiene el dominio del esperma móvil e inflamación | |
| US20200147183A1 (en) | Cyclic acetylcholinesterase c-terminal peptide in the treatment or prevention of cancer or metastasis | |
| US9187566B2 (en) | Mig-7 as a specific anticancer target | |
| EP1987836A1 (en) | Protective staphylococcus aureus vaccine based on cell wall-associated proteins | |
| US20200399313A1 (en) | Compositions and methods for inhibiting cd279 interactions | |
| CA3158138A1 (en) | Antibodies for binding plasminogen | |
| US10774122B2 (en) | ERG targeted therapy | |
| US20180201654A1 (en) | Peptide inhibitors of hausp deubiquitinase | |
| CA2247072A1 (en) | Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof | |
| EP2909235B1 (en) | Polypeptides specifically binding to il-23 | |
| US20250179152A1 (en) | Sars-cov-2 neutralizing synthetic proteins | |
| RU2769223C1 (ru) | Средство и способ терапии и экстренной профилактики заболеваний, вызываемых вирусом SARS-CoV-2 на основе рекомбинантного антитела и гуманизированного моноклонального антитела | |
| CN113398270B (zh) | 一种治疗骨巨细胞瘤的方法 | |
| US20240210419A1 (en) | Compositions and methods for detecting and regulating fibronectin-integrin interactions and signaling |